Clinical significance of delta neutrophil index in the differential diagnosis between septic arthritis and acute gout attack within 24 hours after hospitalization by 諛뺤슜踰� et al.
Observational Study Medicine®
OPENClinical signiﬁcance of delta neutrophil index
in the differential diagnosis between septic
arthritis and acute gout attack within
24hours after hospitalization
Jung Yoon Pyo, MD, Dae Sik Kim, MD, Seung Min Jung, MD, Jason Jungsik Song, MD, PhD,
Yong-Beom Park, MD, PhD, Sang-Won Lee, MD, PhD
∗
Abstract
The most important differential diagnoses of acute monoarticular arthritis are septic arthritis and acute gout attack. Identifying
infection is crucial in preventing the devastating outcome of septic arthritis. The delta neutrophil index (DNI) is a value that
corresponds to the fraction of circulating immature granulocytes. As DNI reﬂects the burden of infection, we evaluated this index as a
differentiating marker between septic arthritis and acute gout attack.
The medical records of 149 patients with septic arthritis and 194 patients with acute gout attack were reviewed. A speciﬁc cell
analyzer, ADVIA 2120, was used to measure DNI. Clinical and laboratory markers associated with predicting septic arthritis were
assessed by using logistic regression.
Patients with septic arthritis showed higher levels of DNI than those with acute gout attack (3.3 vs 0.6%, P< .001). Similar results
were observed in patients without monosodium urate (MSU) crystal conﬁrmation or those with normouricemia (3.3 vs 0.5 and 3.1 vs
0.7%, respectively; P< .001 for both). A DNI level of 1.9% was determined as the cutoff value for predicting septic arthritis. In the
multivariate analysis, DNI was the most powerful independent value for predicting septic arthritis (odds ratio 14.003).
This study showed the possibility of using DNI as a differentiating marker between septic arthritis and acute gout attack at the
crucial early phase. DNI showed its relevance regardless of conﬁrmation of MSU crystal deposition or serum level of uric acid.
Abbreviations: ACR = American College of Rheumatology, AUROC = area under the receiver operator characteristic, CI =
conﬁdence interval, CRP = C-reactive protein, DNI = delta neutrophil index, ESR = erythrocyte sedimentation rate, IGs = immature
granulocytes, LR = likelihood ratio, MPO = myeloperoxidase, MSU = monosodium urate, PMN = polymorphonuclear neutrophil,
WBC = white blood cell.
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Gouty arthritis is the most common inﬂammatory arthritis with
its prevalence markedly increased in the last decade.[1] A typical
gout attack is monoarticular arthritis characterized by acute,
intense pain preferentially involving the lower extremities. SepticEditor: Jenn-Haung Lai.
Funding: This study was supported by a grant from the Korea Health Technology
R&D Project through the Korea Health Industry Development Institute, funded by
the Ministry of Health and Welfare, Republic of Korea (HI14C1324).
The authors have no conﬂicts of interest to disclose.
Supplemental Digital Content is available for this article.
Division of Rheumatology, Department of Internal Medicine, Yonsei University
College of Medicine, Seoul, South Korea.
∗
Correspondence: Sang-Won Lee, Division of Rheumatology, Department of
Internal Medicine, Yonsei University College of Medicine, Yonsei-ro, Seodaemun-
gu, Seoul, South Korea (e-mail: sangwonlee@yuhs.ac).
Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc.
This is an open access article distributed under the Creative Commons
Attribution-No Derivatives License 4.0, which allows for redistribution, commercial
and non-commercial, as long as it is passed along unchanged and in whole, with
credit to the author.
Medicine (2017) 96:30(e7431)
Received: 7 March 2017 / Received in ﬁnal form: 8 June 2017 / Accepted: 11
June 2017
http://dx.doi.org/10.1097/MD.0000000000007431
1arthritis also presents with single joint pain and effusion;
however, there has been no clear manner suggested to distinguish
septic arthritis from acute gout attack based on physical
examination. Differentiating septic arthritis from acute gout
attack is themost important step inmanaging a patient with acute
monoarthritis, as septic arthritis is a crucial joint emergency that
can be rapidly disabling or life-threatening for patients. However,
in real clinical settings, differentiating these 2 disease entities is a
challenge, especially when arthrocentesis is contraindicated or
when polarizing microscope is not available, including in most
primary care units.
Considering the devastating outcome of misdiagnosis, reliable
markers to diagnose septic arthritis are critically needed.
However, neither serum markers such as white blood cell
(WBC) count, C-reactive protein (CRP), or erythrocyte sedimen-
tation rate (ESR) nor radiologic images can exclude the
possibility of septic arthritis in a patient with acute monoarticular
arthritis.[2] In a study of 75 patients with acute monoarthritis,
WBC > 100,000/m or ESR >30mm/h or CRP >100mg/L
increased the likelihood of septic arthritis only minimally
(likelihood ratio [LR] 1.4, 95% conﬁdence interval [CI]
1.1–1.8; LR 1.3, 95% CI 1.1–1.8; LR 1.6, 95% CI 1.1–2.5,
respectively).[3,4] Furthermore, patients with acute gout attack
may also present with elevated CRP, indicating that serum levels
of acute phase reactants do not give reliable cutoffs for
distinguishing between the 2 diseases. Moreover, synovial ﬂuid
Pyo et al. Medicine (2017) 96:30 Medicineanalysis of both septic arthritis and gouty arthritis can present
with a WBC count of >50,000/mm3, and the decreased synovial
glucose level has failed to lead to a diagnosis of septic arthritis.[5,6]
The gold standard for diagnosing septic arthritis is to detect the
microorganism in the synovial ﬂuid of the infected joint;
however, the result requires a few days and a negative ﬁnding
does not exclude the diagnosis, as the sensitivity of the test may be
only 50% to 80%.[7,8] The high serum uric acid level and a
history of gout raise the possibility of gouty arthritis; however,
septic arthritis can be superimposed on gouty arthritis, implying
that physicians should always consider septic arthritis in the
differential diagnosis. Therefore, a novel serum marker for
distinguishing the 2 diseases would be useful in clinical practice
especially in the emergency department.
Infection promotes the production of granulocytes in the bone
marrow, resulting in the presence of immature granulocytes
(IGs).[9,10] The diagnostic and prognostic signiﬁcance of elevated
peripheral IGs on infection and sepsis has been shown.[11–13]
However, manual counting of IGs requires considerable time and
effort, and the accuracy is highly dependent on the examiner. The
delta neutrophil index (DNI) is a novel index reﬂecting a
circulating fraction of IGs that is calculated automatically by
using a cell analyzer which is reported in routine complete blood
count with differentials. It is calculated by the formula as follows:
delta neutrophil index = (neutrophil [%] + eosinophil [%] –
polymorphonuclear neutrophil [PMN][%]). Previous studies
have demonstrated that DNI well correlated with IGs and
showed its relevance as a predictive and prognostic marker of
sepsis. Elevated DNIwas well associated with an increased rate of
disseminated intravascular coagulation, bacteremia, and mortal-
ity in patients with sepsis.[14–16] To date, there are no data onDNI
in relation to septic arthritis. On the basis of the background that
DNI is associated with infection, we evaluated the usefulness of
DNI as a simple index for differentiating septic arthritis from
acute gout attack in this study.
2. Patients and methods
2.1. Patients and data collection
We reviewed the data of 411 patients with a diagnosis of septic
arthritis and 335 patients with a diagnosis of acute gout attack.
All patients had been admitted to Yonsei University Health
System, Severance Hospital, from January 2010 to August 2016.
A clinical data retrieval system was used to screen patients with
the 2 diseases, and we reviewed the medical records to identify
their ﬁnal diagnoses. We ﬁnally recruited 149 patients with septic
arthritis and 194 patients with acute gout attack based on the
inclusion criteria. At the entry of this retrospective study, we
enrolled patients with acute gout attack who met the 1977
American College of Rheumatology (ACR) classiﬁcation criteria
for acute arthritis of primary gout,[17] and we included patients
with septic arthritis who had a positive synovial ﬂuid culture or
those who had deﬁnite macroscopic pus discharge as an operative
ﬁnding.[2] All patients were over 18 years or age and they had
their blood test done before antibiotics or anti-gout medication
administration within 24hours after hospitalization.
We excluded 121 patients who concomitantly had other
infections such as pneumonia and acute pyelonephritis; 105
patients who received antibiotics or anti-gout medications before
the laboratory test; 81 patients who did not fulﬁll the 1977 ACR
criteria; 61 patients who were suspected to have septic arthritis,
but fell short of the inclusion criteria; and 35 patients who had
hematological diseases or malignancies or who had received2chemotherapy or granulocyte colony-stimulating factor. We
reviewed the operative ﬁndings and pathological evaluation of
patients who had undergone surgery, as well as the bacterial
cultures from synovial ﬂuid and blood or any other body ﬂuid
where infection had been suspected (Supplementary Figure 1,
http://links.lww.com/MD/B800). Institutional review board ap-
proval was obtained by Yonsei University, College of Medicine
(ref. 4-2015-0949).2.2. Subgroup analysis
We divided 194 patients with acute gout attack into 2 subgroups
according to the presence of MSU crystals, to evaluate the
usefulness of DNI irrespective of crystal conﬁrmation. A total of
113 of 194 (58.2%) patients were classiﬁed as “patients with
acute gout attack without MSU conﬁrmation,” deﬁned as
patients who did not undergo synovial ﬂuid aspiration.
Furthermore, we gathered patients with septic arthritis and
acute gout attack whose serum uric acid levels were below 7.0
mg/dL and analyzed the difference of DNI. Of the patients, 140 of
149 (94.0%) were classiﬁed as “patients with normouricemic
septic arthritis.” Finally, 79 of 194 (40.7%) patients were
classiﬁed as “patients with acute normouricemic gout attack.”2.3. DNI measurement
DNI was measured by using a speciﬁc automatic cell analyzer
(ADVIA 2120 Healthcare Diagnostics, Forchheim, Germany) as
in our previous study.[18] This cell analyzer counts WBC in 2
independent channels, myeloperoxidase (MPO) and nuclear
lobularity channels. DNI is calculated by using the following
formula: DNI (%) = (the neutrophil subfraction and the
eosinophil subfraction measured in the MPO channel by
cytochemical MPO reaction) – (PMN subfraction measured in
the nuclear lobularity channel by the reﬂected light beam).[19] The
DNI is obtained automatically by subtracting the mature PMN
leukocytes from the MPO-reactive cells. Our institution provides
DNI as a part of routine complete blood count.2.4. Statistical analysis
IBM SPSS software version 23.0 was used to perform statistical
analyses. Data are expressed as means± standard deviation or
absolute and relative frequencies (%). The t-test or chi-square test
was used to assess the differences between acute gout attack and
septic arthritis. As DNI was non-normally distributed, group
differences of DNIwere assessed using theMann–WhitneyU test.
For the variables which showed signiﬁcant differences between
the 2 groups (WBC count, DNI, ESR, CRP, and uric acid), we
used the area under the receiver operator characteristic (AUROC)
curve to determine the optimal cutoffs for predicting septic
arthritis. We performed multivariate logistic regression analysis
to evaluate the independent predictive value for septic arthritis
among the variables which showed signiﬁcant differences in
univariate analysis or had clinical implications. A P-value of< .05
was considered statistically signiﬁcant.
3. Results
3.1. Comparison of variables between patients with septic
arthritis and those with acute gout attack
The mean age and male prevalence of patients with acute gout
attack were higher than those with septic arthritis. Eighty-one of
Table 1
Comparison of variables between patients with acute gout attack and those with septic arthritis.
Variables Patients with acute gout attack (n=194) Patients with septic arthritis (n=149) Total (n=343) P
Age, years 65.0±15.0 60.9±16.4 63.2±15.8 .016
Male sex, n, % 166 (85.6%) 64 (43.0%) 230 (67.1%) < .001
Symptom duration, days 2.9±2.4 3.42±2.3 3.1±2.4 .051
MSU crystals conﬁrmed, n, % 81 (41.8%) N/A 81 (23.6%) N/A
Positive culture, n, % N/A 98 (65.8%) 97 (28.3%) N/A
WBC count, /mm3 9600.0±3000.0 11,200.0±4700.0 10,300.0±3900.0 <.001
DNI, % 0.6±0.9 3.3±4.0 1.8±3.0 <.001
∗
Hemoglobin, g/dL 11.5±2.4 11.9±2.1 11.6±2.3 .093
Platelet count,103/mm3 239.8±104.3 260.3±106.9 248.7±105.7 .075
ESR, mm/h 61.7±33.8 78.2±32.5 69.3±34.2 <.001
CRP, mg/L 76.5±68.7 126.6±104.0 98.7±89.6 <.001
BUN, mg/dL 29.5±21.9 22.7±14.7 26.6±19.4 .001
Creatinine, mg/dL 1.9±1.9 1.2±1.7 1.6±1.8 <.001
Uric acid, mg/dL 7.6±2.5 4.4±1.6 6.3±2.7 <.001
Values are expressed as means± standard deviation or n (%).
BUN=blood urea nitrogen, CRP=C-reactive protein, DNI=delta neutrophil index, ESR= erythrocyte sedimentation rate, MSU=monosodium urate, N/A=not applicable, WBC=white blood cell.
∗
Statistical signiﬁcance test was done by the Mann–Whitney U-test.
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conﬁrmation, whereas 98 of 149 (65.8%) patients with septic
arthritis had positive synovial cultures. Among 149 patients with
septic arthritis, 34 (22.8%) had bacteremia and 136 (91.3%)
underwent surgery. Patients with septic arthritis had signiﬁcantly
higher WBC counts, and ESR and CRP levels but lower uric acid
levels than those with acute gout attack (P< .01 for all). The
mean DNIwas signiﬁcantly higher in patients with septic arthritis
than those with acute gout attack (3.3 vs 0.6%; P< .001)
(Table 1). To assess the inﬂuence of bacterial burden on DNI, we
divided the patients with septic arthritis into 3 subgroups: septic
arthritis with negative cultures (n=51), septic arthritis with
positive synovial cultures (n=66), and septic arthritis with
bacteremia (n=34). Patients with acute gout attack had lower
DNI than all the subgroups of septic arthritis (0.6% for acute
gout attack vs 2.3% for septic arthritis with negative culture
results vs 2.4% for septic arthritis with positive synovial culture
vs 6.3% for septic arthritis with bacteremia, P< .001). Among
patients with septic arthritis, patients with bacteremia showed
higher DNI than those without bacteremia, implying that DNI
increases as the bacterial burden becomes heavier (Supplementa-
ry Figure 2, http://links.lww.com/MD/B800).Table 2
Multivariate analysis of the predictive values for septic arthritis in
patients with acute gout attack and those with septic arthritis
∗
.
Variables Odds ratio 95% Conﬁdence interval P
WBC count ≥14,000.0/mm3 1.888 0.563, 6.337 .303
DNI ≥ 1.9% 14.003 5.683, 34.508 <.001
ESR ≥ 70.0 mm/h 2.505 1.109, 5.657 .027
CRP ≥ 106.0 mg/L 3.032 1.276, 7.209 .012
Uric acid ≥ 7.0 mg/dL 0.031 0.011, 0.086 <.001
CRP=C-reactive protein, DNI=delta neutrophil index, ESR= erythrocyte sedimentation rate, WBC=
white blood cell.
∗
Age and male sex were adjusted.3.2. Optimal cutoffs of variables and multivariate analysis
predicting septic arthritis
We selected the optimal cutoffs for predicting septic arthritis
among variables which showed signiﬁcant differences between
the 2 diseases as follows: WBC ≥ 14,000/mm3 (AUC 0.588, 95%
conﬁdence interval [CI] 0.525, 0.650), DNI ≥ 1.9% (AUC 0.784,
95% CI 0.732, 0.836), ESR ≥ 70.0mm/h (AUC 0.941, 95% CI
0.581, 0.702), CRP ≥ 106.6mg/L (AUC 0.652, 95% CI 0.593,
0.711), and uric acid of 7.0mg/dL (the point widely used for
hyperuricemia in clinical practice). In multivariate regression
analysis, DNI ≥ 1.9% sustained its predictive value for predicting
septic arthritis after adjusting for age and sex (OR 14.003, 95%
CI 5.683, 34.508, P< .001).Moreover, ESR≥ 70mm/h and CRP
≥ 106.0mg/L showed their value for predicting septic arthritis,
but the impact was weaker than that of DNI (OR 2.505, 95% CI
1.109, 5.657, P= .027; OR 3.032, 95% CI 1.276, 7.209,
P= .012, respectively). Furthermore, uric acid ≥ 7.0mg/dL was a3negative predictive value for septic arthritis (OR 0.031, 95% CI
0.011, 0.086, P< .001) (Table 2).3.3. Comparison of patients with septic arthritis and
those with acute gout attack without MSU conﬁrmation
Analyses comparing patients with septic arthritis and those with
acute gout attack without MSU conﬁrmation showed similar
results. Patients with septic arthritis showed higher WBC counts,
ESR, and CRP, but lower serum uric acid level than those with
acute gout attack without MSU conﬁrmation (P< .001 for all).
The DNI was higher in patients with septic arthritis than in those
with acute gout attack without MSU conﬁrmation like the
preceding results (3.3 vs 0.5%, P< .001) (Table 3).
By using AUROC, we determined the optimal cutoff values of
the variables which showed signiﬁcant differences for predicting
septic arthritis: WBC≥ 14,000/mm3 (AUC 0.620, 95%CI 0.553,
0.687), DNI ≥ 1.4% (AUC 0.800, 95% CI 0.746, 0.854), ESR
≥ 69.0mm/h (AUC 0.664, 95% CI 0.593, 0.734), and CRP
≥ 100.0mg/L (AUC 0.689, 95% CI 0.624, 0.753). The uric acid
level of 7.0mg/dL was again used as the cutoff value again. The
results of the multivariate regression model were similar among
all patients. DNI ≥ 1.4% had an inﬂuence on predicting septic
arthritis (OR 9.812, 95% CI 3.803, 25.317, P< .01) stronger
than ESR ≥ 69.0mm/h (OR 2.563, 95% CI 1.015, 6.473,
P= .046) or CRP ≥ 100.0mg/L (OR 5.127, 95% CI 1.756,
14.970, P= .003). Uric acid≥ 7.0mg/dL had a negative predictive
Table 4
Multivariate analysis of the predictive values for cellulitis in
patients with acute gout attack without monosodium urate
conﬁrmation and those with septic arthritis
∗
.
Variables Odds ratio 95% Conﬁdence interval P
WBC count≥14,000.0/mm3 1.979 0.489, 8.003 .339
DNI≥1.4% 9.812 3.803, 25.317 <.001
ESR≥69.0 mm/h 2.563 1.015, 6.473 .046
CRP≥100.0 mg/L 5.127 1.756, 14.970 .003
Uric acid≥7.0 mg/dL 0.036 0.011, 0.118 <.001
CRP=C-reactive protein, DNI=delta neutrophil index, ESR=erythrocyte sedimentation rate, WBC=
white blood cell.
∗
Age and male sex were adjusted.
Table 3
Comparison of variables between patients with acute gout attack without monosodium urate conﬁrmation and those with septic arthritis.
Variables
Patients with acute gout attack without
MSU conﬁrmation (n=113)
Patients with septic
arthritis (n=149) Total (n=262) P
Age, years 70.0±14.7 60.9±16.4 63.5±16.0 .002
Male sex, n, % 97 (85.8%) 64 (43.0%) 161 (61.54%) <.001
Symptom duration, days 2.8±2.3 3.42±2.3 3.2±2.3 .034
WBC count, /mm3 9,200.0±2900.0 11,200.0±4700.0 10,300.0±4200.0 <.001
DNI, % 0.5±0.9 3.3±4.0 2.0±3.4 <.001
∗
Hemoglobin, g/dL 11.3±2.4 11.9±2.1 11.6±2.2 .058
Platelet count, 103/mm3 241.9±109.3 260.3±106.9 252.3±108.1 .170
ESR, mm/h 59.0±33.2 78.2±32.5 70.6±34.0 <.001
CRP, mg/L 64.7±64.8 126.6±104.0 101.3±94.2 <.001
BUN, mg/dL 27.6±19.6 22.7±14.7 24.8±17.1 .026
Creatinine, mg/dL 1.7±1.5 1.2±1.7 1.4±1.6 .017
Uric acid, mg/dL 7.2±2.6 4.4±1.6 5.6±2.5 <.001
Values are expressed as means ± standard deviation or n (%).
BUN=blood urea nitrogen, CRP=C-reactive protein, DNI=delta neutrophil index, ESR= erythrocyte sedimentation rate, MSU=monosodium urate, WBC=white blood cell.
∗
Statistical signiﬁcance test was done by the Mann–Whitney U-test.
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P< .001) (Table 4).
3.4. Comparison of patients with normouricemic septic
arthritis and those with acute normouricemic gout attack
Similarly, patients with normouricemic septic arthritis showed
higher WBC counts, ESR, and CRP, but lower serum uric acidTable 5
Comparison of variables between patients with acute normouricemi
Variables
Patients with acute normouricemic
gout attack (n=79)
Age, years 66.2±14.7
Male sex, n, % 71 (89.9%)
Symptom duration, days 2.6±2.1
WBC count, /mm3 9200.0±3000.0
DNI, % 0.7±1.0
Hemoglobin, g/dL 11.4±2.5
Platelet count,  103/mm3 249.7±109.4
ESR, mm/h 57.1±32.9
CRP, mg/L 75.8±73.1
BUN, mg/dL 21.1±12.3
Creatinine, mg/dL 1.5±1.4
Uric acid, mg/dL 5.3±1.3
Values are expressed as means ± standard deviation or n (%).
CRP=C-reactive protein; BUN, blood urea nitrogen, DNI=delta neutrophil index, ESR=erythrocyte sed
∗
Statistical signiﬁcance test was done by the Mann–Whitney U-test.
4level than those with acute normouricemic gout attack (P< .005
for all). The DNI was higher in patients with septic arthritis than
in those with acute gout attack (3.1 vs 0.7%, P< .001) (Table 5).
The optimal cutoff values of variables having signiﬁcant
differences between the 2 diseases were assessed by using
AUROC: WBC ≥ 14,000/mm3 (AUC 0.616, 95% CI 0.542,
0.691), DNI ≥ 1.9% (AUC 0.757, 95% CI 0.694, 0.820), uric
acid≥ 4.6mg/dL (AUC 0.268, 95%CI 0.196, 0.340), and CRP≥
100.0mg/L (AUC 0.645, 95% CI 0.570, 0.721). Among these
variables which showed statistical differences, DNI ≥ 1.9% had
an independent predictive value for septic arthritis (OR 4.474,
95% CI 1.732, 11.557, P= .002) (Table 6).4. Discussion
The most important differential diagnoses in patients with acute
monoarthritis are septic arthritis and crystal-induced arthritis,
because their treatment strategies differ. This study presents a
novel serum marker that differentiates septic arthritis from acute
gout attack. To date, there has been no single serum marker
which can discriminate these 2 disease entities. Commonly used
acute-phase reactants, such as WBC counts with differentials,c gout attack and those with normouricemic septic arthritis.
Patients with normouricemic
septic arthritis (n=140) Total (n=219) P
60.5±16.8 62.6±16.3 .013
59 (45.4%) 130 (59.4%) <.001
3.5±2.6 3.2±2.5 .023
11,200.0±4700.0 10,500.0±4300.0 .001
3.1±4.1 2.3±3.5 <.001
∗
12.0±2.1 11.8±2.3 .070
270.1±116.3 262.7±114.0 .204
77.4±32.9 70.6±34.2 <.001
123.6±104.9 106.8±97.5 .001
18.9±12.1 19.7±12.2 .199
1.1±1.4 1.2±1.4 .016
4.2±1.3 4.6±1.4 <.001
imentation rate, WBC=white blood cell.
Table 6
Multivariate analysis of the predictive values for cellulitis in
patients with acute normouricemic gout attack and those with
normouricemic septic arthritis
∗
.
Variables Odds ratio 95% Conﬁdence interval P
WBC count ≥ 14,000.0/mm3 2.801 0.647, 12.129 .168
DNI ≥ 1.9% 4.474 1.732, 11.557 .002
ESR ≥ 68.0 mm/h 2.436 0.987, 6.009 .053
CRP ≥ 100.0 mg/L 2.625 0.976, 7.061 .056
Uric acid ≥ 4.6 mg/dL 0.206 0.082, 0.515 .001
CRP=C-reactive protein, DNI=delta neutrophil index, ESR=erythrocyte sedimentation rate, WBC=
white blood cell.
∗
Age and male sex was adjusted.
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diagnosis; however, there are no proper cutoff values to
distinguish septic arthritis from acute gout attack.[20] We have
suggested cutoffs for WBC counts, ESR, and CRP in the present
study; however, after multivariate regression, WBC count lost its
predictive value for septic arthritis and DNI had the most
signiﬁcant power in comparison with ESR or CRP. Similar results
were found when patients without MSU conﬁrmation were
analyzed, which showed that WBC count lost its predictive value
for septic arthritis and DNI was the most powerful predictive
value compared with ESR or CRP. Furthermore, among patients
with normouricemia, along withWBC counts, ESR and CRP also
lost their predictive value after multiple regression analyses. Only
DNI maintained its predictive value for predicting septic arthritis,
implying that DNI was the most potent factor for predicting
septic arthritis.
To date, synovial ﬂuid analysis with obtaining gram stain and
culture results is the gold standard test for diagnosing septic
arthritis in clinical practice. However, as it usually takes more
than 2 days to conﬁrm the results, diagnosis of septic arthritis
cannot be made promptly enough to minimize the subsequent
devastating consequences. Moreover, synovial WBC counts and
PMN cell counts are helpful for diagnosing septic arthritis, in
which the likelihood of the disease increases as the synovial ﬂuid
WBC counts increases.[21,22] Nonetheless, these counts are
insufﬁcient to differentiate septic arthritis from acute gout attack
because gouty arthritis also often presents with synovial ﬂuid
WBC count of >50,000/mm3 and PMN dominance. In fact, in
our present population, 19 of 149 (12.8%) patients with septic
arthritis presented with synovial WBC count less than 50,000/
mm3 and 32 of 128 (25%) patients with acute gout attack who
undergone synovial ﬂuid analysis showed synovial WBC count
more than 50,000/mm3. Therefore, there is a need for a
laboratory modality complementary to traditionally used
methods for diagnosing of septic arthritis.
Hyperuricemia is the key pathophysiology of gout; however, it
does not rule out septic arthritis because two-thirds or more
patients with hyperuricemia are asymptomatic and not present-
ing with gout.[23] In our data, the uric acid level showed a
reasonable potential for diagnosing acute gout attack. However,
ruling out septic arthritis is crucial in managing acute arthritis,
and the possibility of the coexistence of the 2 diseases should
always be considered. A previous study by Lenski and Scherer[6]
also showed similar results presenting a signiﬁcant difference of
uric acid level between septic arthritis and acute gout attack.
However, the authors concluded that the uric acid level may help
in distinguishing acute gout attack from other inﬂammatory
arthritis but is insufﬁcient to rule out septic arthritis.5As DNI is the value reﬂecting the fraction of IGs, it is well
correlated with sepsis severity, detection rate by blood cultures,
disseminated intravascular coagulation scores, and
mortality.[14–16] The present data also supported the ﬁndings
that DNI increase becomes higher as the infection becomes more
severe. The highest DNI was 6.1% in patients with bacteremia
among those with septic arthritis. This result was well
reproduced, similar to previously published studies, showing
DNI levels of 5.2% to 6.5% as the cutoff values for
bacteremia.[18,24] The mean DNI value was lower in patients
with septic arthritis without bacteremia than in those with
bacteremia; however, it was signiﬁcantly higher than in patients
with acute gout attack. Therefore, the present study demonstrat-
ed the possibility of using DNI as a differentiating marker
between septic arthritis and acute gout attack.
Acute gout attack differs from septic arthritis in that acute gout
attack is self-limited despite the presence of severe pain. Previous
studies have observed increased levels of transforming growth
factor beta-1 and interleukin-1 receptor antagonist in the
synovial ﬂuid when serially measured.[25,26] These anti-inﬂam-
matory cytokines might be a mechanism of spontaneous
resolution of acute gout attack. On the other hand, septic
arthritis needs immediate proper antibiotics, unless it devastates
the affected joint and even leads to sepsis. This is the point where
we suggest a hypothesis for the mechanism by which DNI
differentiates between acute gout attack and septic arthritis.
Without a self-limiting process such as acute gout attack,
inﬂammation in patients with septic arthritis will sustain and
activate the bone marrow continuously, resulting in increased
DNI.
Several limitations of this study should bementioned. First, this
study was performed at a single center and the results were
analyzed retrospectively; thus, further prospective analyses with a
larger population are needed to conﬁrm the value and accurately
measure the sensitivity and speciﬁcity. Second, a speciﬁc type of
cell analyzer is needed to measure the DNI, thus restricting its
clinical application. Third, the variation of DNI according to time
is unknown; thus, the most precise time point to measure DNI
after the onset of symptoms is unclear. Last, there was no patient
in this present study who had superimposed septic arthritis in a
patient who previously had gout. Since it is critical to identify
superimposed infection in a patient with gout, future researches
would clarify these limitations and contribute to the utilization of
DNI in real clinical practice.
In conclusion, this study demonstrates the relevance of DNI as
a predictive value for septic arthritis in patients who are suspected
as having acute gout attack. We propose that in patients with a
DNI of ≥1.9%, the possibility of septic arthritis should always be
considered with a high priority, especially in patients whose
diagnosis is unclear between acute gout attack and septic
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